FI980902A - Levosimendaanin stabiileja koostumuksia - Google Patents

Levosimendaanin stabiileja koostumuksia

Info

Publication number
FI980902A
FI980902A FI980902A FI980902A FI980902A FI 980902 A FI980902 A FI 980902A FI 980902 A FI980902 A FI 980902A FI 980902 A FI980902 A FI 980902A FI 980902 A FI980902 A FI 980902A
Authority
FI
Finland
Prior art keywords
levosimendan
stable compositions
compositions
stability
improving
Prior art date
Application number
FI980902A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI980902A0 (fi
Inventor
Ilkka Larma
Maarit Harjula
Original Assignee
Orion Yhtymae Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oyj filed Critical Orion Yhtymae Oyj
Priority to FI980902A priority Critical patent/FI980902A/fi
Publication of FI980902A0 publication Critical patent/FI980902A0/fi
Priority to BR9909867-9A priority patent/BR9909867A/pt
Priority to AT99916943T priority patent/ATE231395T1/de
Priority to MXPA00010368A priority patent/MXPA00010368A/es
Priority to CZ20003779A priority patent/CZ290911B6/cs
Priority to NZ507455A priority patent/NZ507455A/en
Priority to PT99916943T priority patent/PT1079834E/pt
Priority to SI9930223T priority patent/SI1079834T1/xx
Priority to JP2000545535A priority patent/JP4475809B2/ja
Priority to CA002329232A priority patent/CA2329232C/en
Priority to EEP200000616A priority patent/EE04143B1/xx
Priority to AU35248/99A priority patent/AU756338B2/en
Priority to GEAP19995638A priority patent/GEP20032942B/en
Priority to EA200001097A priority patent/EA002428B1/ru
Priority to SK1555-2000A priority patent/SK284600B6/sk
Priority to ES99916943T priority patent/ES2191426T3/es
Priority to DK99916943T priority patent/DK1079834T3/da
Priority to DE69905034T priority patent/DE69905034T2/de
Priority to IL13895099A priority patent/IL138950A0/xx
Priority to HU0105446A priority patent/HUP0105446A3/hu
Priority to KR1020007011789A priority patent/KR100590622B1/ko
Priority to TR2000/03101T priority patent/TR200003101T2/xx
Priority to PL343722A priority patent/PL192274B1/pl
Priority to IDW20002368A priority patent/ID26650A/id
Priority to US09/673,793 priority patent/US6531458B1/en
Priority to CNB998053805A priority patent/CN1165309C/zh
Priority to EP99916943A priority patent/EP1079834B1/en
Priority to PCT/FI1999/000331 priority patent/WO1999055337A1/en
Priority to YUP-640/00A priority patent/RS49955B/sr
Publication of FI980902A publication Critical patent/FI980902A/fi
Priority to IL138950A priority patent/IL138950A/en
Priority to ZA200005630A priority patent/ZA200005630B/en
Priority to HR20000703A priority patent/HRP20000703B1/xx
Priority to NO20005312A priority patent/NO318575B1/no
Priority to BG104958A priority patent/BG64766B1/bg
Priority to HK01102147A priority patent/HK1031998A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FI980902A 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia FI980902A (fi)

Priority Applications (35)

Application Number Priority Date Filing Date Title
FI980902A FI980902A (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia
DE69905034T DE69905034T2 (de) 1998-04-23 1999-04-23 Stabile zusammensetzungen enthaltend levosimendan und alginsäure
DK99916943T DK1079834T3 (da) 1998-04-23 1999-04-23 Stabile sammensætninger omfattende levosimendan og alginsyre
IL13895099A IL138950A0 (en) 1998-04-23 1999-04-23 Stable compositions comprising levosimendan and alginic acid
MXPA00010368A MXPA00010368A (es) 1998-04-23 1999-04-23 Composiciones estables que comprenden levosimendan y acido alginico.
AT99916943T ATE231395T1 (de) 1998-04-23 1999-04-23 Stabile zusammensetzungen enthaltend levosimendan und alginsäure
NZ507455A NZ507455A (en) 1998-04-23 1999-04-23 Levosimendan composition with alginic acid as a stability improving agent
HU0105446A HUP0105446A3 (en) 1998-04-23 1999-04-23 Pharmaceutical compositions comprising levosimendan and alginic acid
SI9930223T SI1079834T1 (en) 1998-04-23 1999-04-23 Stable compositions comprising levosimendan and alginic acid
JP2000545535A JP4475809B2 (ja) 1998-04-23 1999-04-23 レボシメンダンおよびアルギン酸からなる安定な組成物
CA002329232A CA2329232C (en) 1998-04-23 1999-04-23 Stable compositions comprising levosimendan and alginic acid
EEP200000616A EE04143B1 (et) 1998-04-23 1999-04-23 Levosimendani ja alghappe stabiilsed koostised
AU35248/99A AU756338B2 (en) 1998-04-23 1999-04-23 Stabile compositions comprising levosimendan and alginic acid
GEAP19995638A GEP20032942B (en) 1998-04-23 1999-04-23 Stabile Pharmaceutical Compositions Comprising Levosimendan and Alginic Acid
EA200001097A EA002428B1 (ru) 1998-04-23 1999-04-23 Стабильные композиции, содержащие левозимендан и альгиновую кислоту
SK1555-2000A SK284600B6 (sk) 1998-04-23 1999-04-23 Farmaceutický prostriedok obsahujúci levosimendan
ES99916943T ES2191426T3 (es) 1998-04-23 1999-04-23 Composiciones estables que comprenden levosimendano y acido alginico.
BR9909867-9A BR9909867A (pt) 1998-04-23 1999-04-23 Composições estáveis contendo levosimendan e ácido algìnico
YUP-640/00A RS49955B (sr) 1998-04-23 1999-04-23 Stabilne kompozicije koje sadrže levosimendan i alginsku kiselinu
CZ20003779A CZ290911B6 (cs) 1998-04-23 1999-04-23 Stabilní prostředky obsahující levosimendan a kyselinu alginovou
PT99916943T PT1079834E (pt) 1998-04-23 1999-04-23 Composicoes estaveis que compreendem levosimendan e acido alginico
KR1020007011789A KR100590622B1 (ko) 1998-04-23 1999-04-23 레보시멘단과 알긴산을 포함하는 안정한 조성물
TR2000/03101T TR200003101T2 (tr) 1998-04-23 1999-04-23 Levosimendan ve aljinik asit içeren kararlı kompozisyonlar
PL343722A PL192274B1 (pl) 1998-04-23 1999-04-23 Kompozycja farmaceutyczna zawierająca lewosimendan
IDW20002368A ID26650A (id) 1998-04-23 1999-04-23 Komposisi-komposisi stabil yang terdiri dari levosimendan dan asam alginik
US09/673,793 US6531458B1 (en) 1998-04-23 1999-04-23 Stable compositions comprising levosimendan and alginic acid
CNB998053805A CN1165309C (zh) 1998-04-23 1999-04-23 含有左西孟旦和藻酸的稳定组合物
EP99916943A EP1079834B1 (en) 1998-04-23 1999-04-23 Stable compositions comprising levosimendan and alginic acid
PCT/FI1999/000331 WO1999055337A1 (en) 1998-04-23 1999-04-23 Stabile compositions comprising levosimendan and alginic acid
IL138950A IL138950A (en) 1998-04-23 2000-10-11 Stable compounds containing bosimandan and alginic acid
ZA200005630A ZA200005630B (en) 1998-04-23 2000-10-12 Stabile compositions comprising levosimendan and alginic acid.
HR20000703A HRP20000703B1 (en) 1998-04-23 2000-10-19 Stabile compositions levosimendan and alginic acid
NO20005312A NO318575B1 (no) 1998-04-23 2000-10-20 Stabile sammensetninger som omfatter levosimendan og alginsyre
BG104958A BG64766B1 (bg) 1998-04-23 2000-11-17 Стабилни състави, съдържащи левосимендан и алгинова киселина
HK01102147A HK1031998A1 (en) 1998-04-23 2001-03-26 Stable compositions comprising levosimendan and alginic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI980902A FI980902A (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia

Publications (2)

Publication Number Publication Date
FI980902A0 FI980902A0 (fi) 1998-04-23
FI980902A true FI980902A (fi) 1999-10-24

Family

ID=8551576

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980902A FI980902A (fi) 1998-04-23 1998-04-23 Levosimendaanin stabiileja koostumuksia

Country Status (33)

Country Link
US (1) US6531458B1 (cs)
EP (1) EP1079834B1 (cs)
JP (1) JP4475809B2 (cs)
KR (1) KR100590622B1 (cs)
CN (1) CN1165309C (cs)
AT (1) ATE231395T1 (cs)
AU (1) AU756338B2 (cs)
BG (1) BG64766B1 (cs)
BR (1) BR9909867A (cs)
CA (1) CA2329232C (cs)
CZ (1) CZ290911B6 (cs)
DE (1) DE69905034T2 (cs)
DK (1) DK1079834T3 (cs)
EA (1) EA002428B1 (cs)
EE (1) EE04143B1 (cs)
ES (1) ES2191426T3 (cs)
FI (1) FI980902A (cs)
GE (1) GEP20032942B (cs)
HK (1) HK1031998A1 (cs)
HR (1) HRP20000703B1 (cs)
HU (1) HUP0105446A3 (cs)
ID (1) ID26650A (cs)
IL (2) IL138950A0 (cs)
MX (1) MXPA00010368A (cs)
NO (1) NO318575B1 (cs)
NZ (1) NZ507455A (cs)
PL (1) PL192274B1 (cs)
PT (1) PT1079834E (cs)
RS (1) RS49955B (cs)
SK (1) SK284600B6 (cs)
TR (1) TR200003101T2 (cs)
WO (1) WO1999055337A1 (cs)
ZA (1) ZA200005630B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
JPWO2002064120A1 (ja) * 2001-02-13 2004-06-10 大正製薬株式会社 内服ゲル製剤
US20080194567A1 (en) * 2005-03-14 2008-08-14 Piero Pollesello Combination Treatment for Enhancing Diuresis
PL3370693T3 (pl) * 2015-11-06 2020-07-13 Carinopharm Gmbh Ulepszone preparaty lewosimendanu do podawania dożylnego w postaci roztworów do wlewów lub wstrzykiwań i koncentratu do wlewów
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
NZ203684A (en) * 1982-04-05 1986-06-11 Merck Sharp & Dohme Granular formulation for the stabilization of unstable drugs or food supplements
EP0123291A2 (en) 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
US4906630A (en) * 1985-11-22 1990-03-06 Rorer Pharmaceutical Corporation Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds
US4716042A (en) 1986-06-16 1987-12-29 American Home Products Corporation Stabilized coated aspirin tablets
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia

Also Published As

Publication number Publication date
CN1165309C (zh) 2004-09-08
RS49955B (sr) 2008-09-29
ATE231395T1 (de) 2003-02-15
HUP0105446A2 (hu) 2002-07-29
WO1999055337A1 (en) 1999-11-04
SK284600B6 (sk) 2005-07-01
NO20005312L (no) 2000-11-21
EP1079834A1 (en) 2001-03-07
KR20010072577A (ko) 2001-07-31
BG64766B1 (bg) 2006-03-31
FI980902A0 (fi) 1998-04-23
TR200003101T2 (tr) 2001-01-22
HUP0105446A3 (en) 2002-09-30
JP4475809B2 (ja) 2010-06-09
EA002428B1 (ru) 2002-04-25
DE69905034D1 (de) 2003-02-27
IL138950A (en) 2006-08-20
AU756338B2 (en) 2003-01-09
HK1031998A1 (en) 2001-07-06
BR9909867A (pt) 2000-12-19
HRP20000703A2 (en) 2001-04-30
CZ290911B6 (cs) 2002-11-13
NZ507455A (en) 2002-02-01
PL192274B1 (pl) 2006-09-29
YU64000A (sh) 2002-12-10
HRP20000703B1 (en) 2009-11-30
DK1079834T3 (da) 2003-04-07
MXPA00010368A (es) 2002-07-02
CZ20003779A3 (en) 2001-05-16
CA2329232A1 (en) 1999-11-04
CN1298303A (zh) 2001-06-06
EP1079834B1 (en) 2003-01-22
EA200001097A1 (ru) 2001-04-23
DE69905034T2 (de) 2003-09-04
PT1079834E (pt) 2003-04-30
NO20005312D0 (no) 2000-10-20
EE200000616A (et) 2002-06-17
BG104958A (en) 2001-07-31
ES2191426T3 (es) 2003-09-01
GEP20032942B (en) 2003-04-25
JP2002512964A (ja) 2002-05-08
US6531458B1 (en) 2003-03-11
SK15552000A3 (sk) 2001-05-10
NO318575B1 (no) 2005-04-11
IL138950A0 (en) 2001-11-25
PL343722A1 (en) 2001-09-10
CA2329232C (en) 2007-10-30
ZA200005630B (en) 2002-01-14
AU3524899A (en) 1999-11-16
ID26650A (id) 2001-01-25
KR100590622B1 (ko) 2006-06-19
EE04143B1 (et) 2003-10-15

Similar Documents

Publication Publication Date Title
BR9806752A (pt) Ftalazinonas.
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
EA200300171A1 (ru) Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения
BR9810450A (pt) Derivados de ácido barbitúrico com atividade antimetastática e antitumor
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
NO20022201L (no) Lösninger inneholdende Epinastin
ATE232873T1 (de) Phosphonsaürederivate als ptp-1b-inhibitoren
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
ATE297188T1 (de) Stabilisierte ascorbinsäure-lösungen
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
FI980902A (fi) Levosimendaanin stabiileja koostumuksia
DE69725457D1 (de) Piperazinderivate als neurokinin-antagonisten
NO975028D0 (no) Piperazinoderivater som neurokininantagonister
DE60230155D1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
MD554G2 (ro) Derivaţi noi ai triazolpirimidinelor, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice care le conţin
ATE374180T1 (de) N-acylpyrrolidin-2-ylalkylbenzamidin-derivate als inhibitoren von factor xa
DE60043228D1 (de) Herstellungsverfahren von 2-cyanopyridinen
HUP9801925A1 (hu) Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
ATE184155T1 (de) Verwendung der jodwasserstoffsäure als aphrodisiakum
DE60218726D1 (de) Verwendung von 4-oxo-butansäure derivaten zur behandlung der entzündung